1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generics: North America (NAFTA) Industry Guide

Generics: North America (NAFTA) Industry Guide

  • January 2016
  • -
  • MarketLine
  • -
  • 67 pages

Introduction

The NAFTA Generics industry guide provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA generics market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA generics market
* Leading company profiles reveal details of key generics market players’ NAFTA operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA generics market with five year forecasts
* Compares data from the US, Canada and Mexico, alongside individual chapters on each country

Highlights

The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The generics industry within the NAFTA countries had a total market value of $105.4 billion in 2015.The Mexico was the fastest growing country, with a CAGR of 14.2% over the 2011-15 period.
Within the generics industry, the US is the leading country among the NAFTA bloc, with market revenues of $94.0 billion in 2015. This was followed by Mexico and Canada, with a value of $6.6 and $4.9 billion, respectively.
The US is expected to lead the generics industry in the NAFTA bloc, with a value of $128.0 billion in 2020, followed by Mexico and Canada with expected values of $11.1 and $5.3 billion, respectively.

Your key questions answered

* What was the size of the NAFTA generics market by value in 2015?
* What will be the size of the NAFTA generics market in 2020?
* What factors are affecting the strength of competition in the NAFTA generics market?
* How has the market performed over the last five years?
* How large is the NAFTA generics market in relation to its regional counterparts?

Table Of Contents

Generics: North America (NAFTA) Industry Guide
INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Definitions
NAFTA GENERICS
Industry Outlook
GENERICS IN CANADA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
GENERICS IN MEXICO
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
GENERICS IN THE UNITED STATES
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
COMPANY PROFILES
Leading companies
APPENDIX
Methodology
About MarketLine

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.